The improvement in the hypertension control in Finland started in the 1970s by the activities of the North Karelia Project, a comprehensive programme for the control of cardiovascular diseases. The blood pressure level of the population has had a continuous downward trend according to the population surveys conducted every fifth year since 1972 and the rule of halves has changed to the rule of two-thirds. The serum cholesterol level has decreased among hypertensives, even though it is still higher than among normotensives; the patients with antihypertensive drug treatment smoke less than the rest of the population. However, the situation is far from optimal; BP levels are high and body mass index is continuously increasing among the patients. The need for intensifying both pharmacological and nonpharmacological treatment among the hypertensives on a large scale is obvious.
Introduction
ln 1972 due to the highest cardiovascular disease (CVD) mortality rate in the world, the North Karelia Project began as a national pilot and demonstration programme for CVD prevention. A reduction in the population levels of the well-established risk factors (smoking, elevated cholesterol, and elevated blood pressure (BP)) was the main intermediate objective.
A comprehensive community-based intervention involving health services, nongovernmental organisations, industry, media and public policy was developed. After the initial period (1972) (1973) (1974) (1975) (1976) (1977) , the project experiences have been actively used for heart health programmes in Finland. The evaluations, involving population surveys and disease registers, have shown that population risk-factor levels have greatly reduced and consequently the age-adjusted coronary heart disease mortality rate among 35-to 64-year-old male population has reduced from 1970 to 1995 by 73% in North Karelia and 65% in all of Finland. 1 Hypertension programme as an essential part of the North Karelia Project aimed at reduction of the prevalence of high BP among the population. The specific objectives were: (1) to detect as many hypertensive people as possible; (2) to control BP in as many of them as possible; (3) to establish uniform and appropriate diagnostic and therapeutic methods among physicians; and (4) to gather information on the epidemiology of hypertension and on hypertension-related functions of the health services. Hypertension programme activities were targeted at the entire population and at reorganising the care of the patients. The results showed that hypertension awareness among the general population increased, both SBP and DBP decreased and treatment was more effective in North Karelia than in the reference area from 1972 to 1977. 2 According to a separate analysis, the programme proved to be cost effective. 3 The national implementation of the activities in hypertension control started in the late 1970s after careful evaluation of the effects and experiences of the Project. Parallel to the national implementation, some further activities were tested in North Karelia, which maintained its role as a national demonstration area until the late 1990s. One of the activities after the Project was North Karelia Salt Project, which produced information for the national authorities about the exceptionally high level of salt intake in the area as well as obstacles in attempts to change people's behaviour in terms of salt intake. 4, 5 The purpose of this article is to summarise the development of hypertension care in Finland since the 1980s and to discuss both positive contributing factors and obstacles in the development of hypertension care in the community.
Hypertension control in Finland since the 1980s
Implementation of the activities to improve hypertension care at the national level started already in 1976, when the National Hypertension Committee was nominated by the Ministry of Health. The Committee (1978) made practical recommendations for the detection, diagnosis and treatment of the patients as well as for training of personnel and the prevention of hypertension among the entire population. Also, the responsibilities of different authorities and other interest groups were defined. The purpose was to make a local plan for each of the 12 provinces in Finland. This activity took hypertension as a public health problem into the national agenda, and practical recommendations formed an excellent basis for reorganising the care, if needed. The plan placed emphasis on the collaboration between community health centres in primary care and the specialised hospitals. The work of the Committee created several activities, of which worth mentioning is a national meeting in 1980 for salt as a risk of hypertension. Representatives of food industry, health and nutrition science, health care and relevant administration started the dialogue on the health consequences of excess salt intake and of possible activities for controlling the problem. Increasing awareness among the population at large has guaranteed a continuous demand for less salty products, which eventually have become available in a wide variety. Labelling of food products, including sodium and salt, started in the late 1980s, when also food products were classified according to salt content into three categories, strong, normal and reduced salt content by the Ministry of Trade and Industry.
The role of the medical society has become more prominent since the 1990s. The evidence-based guidelines for the diagnosis, treatment and followup of hypertensive patients were developed for health care first in 1994 and later in 2000. Special guidelines for the prevention of hypertension were agreed upon in 1994. 6 Development of hypertension control from the 1980s and in the 1990s in Finland Four independent cross-sectional standardised surveys were conducted among the 25-64 year-old population in Eastern and Southwestern Finland during 1982-1997. Altogether, 29 036 men and women participated in these surveys. In Tables 1  and 2 , some indicators of hypertension care in the pooled population of the study areas are presented.
These findings are based on the publications by Kastarinen et al. [7] [8] [9] SBP decreased significantly in all groups, when the participants were classified according to their BP level and treatment status: normotensive, unaware hypertensive, aware but untreated hypertensive and treated hypertensive. The fall in DBP was significant only in drug-treated hypertensive men and women. The mean total cholesterol decreased in all groups, but BMI increased significantly in all groups except in aware hypertensive women without antihypertensive drug treatment. The prevalence of smoking also decreased significantly in both treated hypertensive patients and normotensive subjects in men, but increased significantly in treated hypertensive women.
During the entire 15 years, the mean SBP and the prevalence of hypertension decreased significantly in the study areas, but the fall in DBP was significant only in eastern Finland. 10 The proportion of those aware of their condition among hypertensives increased from 55 to 76% in men and from 73 to 85% in women. The proportion of hypertensives with adequately controlled BP (SBP o160 mmHg and DBP o95 mmHg) increased from 8 to 22% in men and from 16 to 35% in women.
Cost of hypertension care
The cost-effectiveness of the hypertension programme of the North Karelia Project was assessed for the population below 65 years from 1972 to 1977. 3 Costs per unit of effect were more favourable than in other heart disease interventions. The authors conclude that unlike the other interventions, however, hypertension treatment prevents the appearance of CVD and thus prevents the sudden deaths that these programmes cannot address. Hypertension treatment also preserves the ability to earn a living. As results showed that antihyper- 
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tensive medication consumed 59% of costs, hypertension care would be more cost-effective if nonpharmacologic treatment of hypertension and primary prevention of hypertension could reduce the need for drug treatment. Since the 1970s, hypertension treatment has changed due to introduction of calcium-channel blockers and ACE inhibitors. The average cost per treated patient was at 1990, two and a half-fold higher in 1990 than in 1972 in North Karelia.
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In the 1990s, the treatment regimens continued to change, which started during the previous decade as shown in Figure 1 . ACE inhibitors are currently the most common antihypertensive drugs in Finland. 12 According to the statistics, altogether 474 720 patients, 8.6% of the entire population, were entitled to the special reimbursement for drug costs for hypertension, which was the most common single disease reimbursement comprising 23% of the total 0.5 billion EUR in 2001. The mean cost of antihypertensive drug treatment per recipient was 322 EUR in 2001.
Discussion
The BP levels in Finland are still high by international standards. 13 Control of hypertension is not satisfactory in spite of the favourable development. The trend in control of hypertension is in accord with the development seen in some other countries. 14, 15 Most alarming is the finding that obesity increases among both hypertensive patients and among the normotensives. Obesity as one of the main contributing risk factors for hypertension Normotension was defined as systolic blood pressure o160 mmHg and diastolic blood pressure o95 mmHg and no antihypertensive drug treatment. 
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works against the downward trend in the mean blood pressure level among the population. It also, most probably, diminishes the effects of antihypertensive drugs. The increase in prescription of more expensive antihypertensive agents than before also deserves attention. The fact that already Finnish hypertensive patients themselves constitutes along with the Portuguese patients, the highest proportion among European Community, for their drug treatment, warrants attention. Even though the bulk of patients can afford the costs, the most vulnerable groups of the society are in danger of becoming noncompliant due to the costs of drugs.
There is an obvious need for intensifying activities in health care towards comprehensive patient counselling on lifestyle, like diet and physical activity among patients, with or without antihypertensive drug treatment. Minor changes in the treatment and proper follow-up of the patients contribute to significant benefits in terms of BP control and CVD risk as the controlled trial in primary care in Finland has recently shown. 16 
